HOMEVULNERABILITIESCVE-2026-33529
LOW

CVE-2026-33529

CWE-22Published: March 26, 2026· Updated: Mar 30, 2026

3.3
CVSS v3.1
EPSS:0.04%probability of exploitation in 30 daysPercentile:12.4th

Official Description

Zoraxy is a general purpose HTTP reverse proxy and forwarding tool. Prior to version 3.3.2, an authenticated path traversal vulnerability in the configuration import endpoint allows an authenticated user to write arbitrary files outside the config directory, which can lead to RCE by creating a plugin. Version 3.3.2 patches the issue.

NVD Source

Technical Analysis

CVE-2026-33529 can be exploited remotely over the network without requiring physical or adjacent access, significantly expanding the attack surface for threat actors.

Exploitation requires high privileges, which limits the exposure to scenarios where an attacker has already gained initial access.

CVSS v3.1 Vector Breakdown

Exploitability
Attack VectorNetwork
Attack ComplexityHigh
Privileges Req.High
User InteractionNone
ScopeUnchanged
Impact
ConfidentialityLow
IntegrityLow
AvailabilityNone
CVSS:3.1/AV:N/AC:H/PR:H/UI:N/S:U/C:L/I:L/A:N

Exploit & PoC Resources

NO KNOWN EXPLOITNo public exploit confirmed at this time
External links open in a new tab. Always verify in a controlled environment before use.

All References (3)

Quick Facts

CVE IDCVE-2026-33529
CVSS Score3.3 / 10
SeverityLOW
WeaknessCWE-22
CISA KEVNo
EPSS (30d)0.04%
PublishedMar 26, 2026

Related CVEs (CWE-22)

Recommended Actions

  • Apply vendor patches immediately
  • Monitor CVE-2026-33529 in threat intel feeds
  • Review IDS/IPS signatures for exploitation attempts
Data sourced from NVD (NIST), CISA KEV, and EPSS (FIRST). Analysis generated by CTIWATCH.COM. CVE data is provided under the NVD usage policy.